Irinotecan (Liposomal)
Trade Name: Onivyde®
Irinotecan (liposomal) is the generic name for the trade name drug Onivyde. In some cases, health care professionals may use the trade name Onivyde when referring to the generic drug name irinotecan liposomal.

Drug type: Irinotecan (liposomal) is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as a "Topoisomerase I Inhibitor." (For more detail, see "How Irinotecan (liposomal) Works" below)

What Irinotecan (Liposomal) Is Used For :
For the treatment of patients with locally advanced or metastatic urothelial carcinoma who:
  • Metastatic pancreatic cancer (in combination with flurouracil and leucovorin)

Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.

How Irinotecan (Liposomal) Is Given :
  • This drug is administered by infusion into a vein (intravenous, IV).

The amount of irinotecan (liposomal) that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition you have. Your doctor will determine your exact dosage and schedule.